These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23280317)

  • 1. Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.
    Lee JM; Hays JL; Noonan AM; Squires J; Minasian L; Annunziata C; Wood BJ; Yu M; Calvo KR; Houston N; Azad N; Kohn EC
    Cancer; 2013 Apr; 119(7):1357-64. PubMed ID: 23280317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer.
    Tsai EB; Pomykala K; Ruchalski K; Genshaft S; Abtin F; Gutierrez A; Kim HJ; Li A; Adame C; Jalalian A; Wolf B; Garon EB; Goldman JW; Suh R
    Radiology; 2018 Apr; 287(1):326-332. PubMed ID: 29232184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and safety of ultrasound-guided percutaneous needle core biopsy of renal masses: A single center experience in China.
    Wang X; Lv Y; Xu Z; Aniu M; Qiu Y; Wei B; Li X; Wei Q; Dong Q; Lin T
    Medicine (Baltimore); 2018 Mar; 97(13):e0178. PubMed ID: 29595650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance.
    Alle N; Tan N; Huss J; Huang J; Pantuck A; Raman SS
    Abdom Radiol (NY); 2018 Jul; 43(7):1813-1819. PubMed ID: 29079986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of CT-guided Core Needle Biopsy in Diagnosing Spinal Lesions: A Comparison Study.
    Liang Y; Liu P; Jiang LB; Wang HL; Hu AN; Zhou XG; Li XL; Lin H; Wu D; Dong J
    Orthop Surg; 2019 Feb; 11(1):60-65. PubMed ID: 30767427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
    Ren Z; Xu J; Bai Y; Xu A; Cang S; Du C; Li Q; Lu Y; Chen Y; Guo Y; Chen Z; Liu B; Jia W; Wu J; Wang J; Shao G; Zhang B; Shan Y; Meng Z; Wu J; Gu S; Yang W; Liu C; Shi X; Gao Z; Yin T; Cui J; Huang M; Xing B; Mao Y; Teng G; Qin Y; Wang J; Xia F; Yin G; Yang Y; Chen M; Wang Y; Zhou H; Fan J;
    Lancet Oncol; 2021 Jul; 22(7):977-990. PubMed ID: 34143971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.
    Dowlati A; Haaga J; Remick SC; Spiro TP; Gerson SL; Liu L; Berger SJ; Berger NA; Willson JK
    Clin Cancer Res; 2001 Oct; 7(10):2971-6. PubMed ID: 11595684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study.
    Lynch TJ; Spigel DR; Brahmer J; Fischbach N; Garst J; Jahanzeb M; Kumar P; Vidaver RM; Wozniak AJ; Fish S; Flick ED; Leon L; Hazard SJ; Kosty MP;
    J Thorac Oncol; 2014 Sep; 9(9):1332-9. PubMed ID: 25122429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfemoral Transcaval Core-Needle Liver Biopsy: An Alternative to Transjugular Liver Biopsy.
    Cynamon J; Shabrang C; Golowa Y; Daftari A; Herman O; Jagust M
    J Vasc Interv Radiol; 2016 Mar; 27(3):370-5. PubMed ID: 26723528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.
    Hoyle M; Crathorne L; Peters J; Jones-Hughes T; Cooper C; Napier M; Tappenden P; Hyde C
    Health Technol Assess; 2013 Apr; 17(14):1-237. PubMed ID: 23547747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial.
    Reck M; Mok TSK; Nishio M; Jotte RM; Cappuzzo F; Orlandi F; Stroyakovskiy D; Nogami N; Rodríguez-Abreu D; Moro-Sibilot D; Thomas CA; Barlesi F; Finley G; Lee A; Coleman S; Deng Y; Kowanetz M; Shankar G; Lin W; Socinski MA;
    Lancet Respir Med; 2019 May; 7(5):387-401. PubMed ID: 30922878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Yield and Safety of Computed Tomography-guided Mediastinal Core Needle Biopsies.
    de Margerie-Mellon C; de Bazelaire C; Amorim S; Brice P; Tazi A; Brière J; Frija J; de Kerviler E
    J Thorac Imaging; 2015 Sep; 30(5):319-27. PubMed ID: 25978277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences.
    Madariaga A; Bhat G; Wilson MK; Li X; Cyriac S; Bowering V; Hunt W; Gutierrez D; Bonilla L; Kasherman L; McMullen M; Wang L; Ghai S; Dhani NC; Oza AM; Lheureux S
    Am J Obstet Gynecol; 2021 Dec; 225(6):658.e1-658.e9. PubMed ID: 34174204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked safety and high diagnostic yield of freehand ultrasound-guided core-needle biopsies performed by pulmonologists.
    Gershman E; Vaynshteyn I; Freidkin L; Pertzov B; Rosengarten D; Kramer MR
    Thorac Cancer; 2022 Jun; 13(11):1577-1582. PubMed ID: 35474608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center.
    Lee K; Lee SJ; Yoon S; Ryoo BY; Kim SW; Choi SH; Lee SM; Chae EJ; Park Y; Jang SJ; Park SY; Yoon YK; Park SH; Kim TW
    PLoS One; 2019; 14(8):e0221065. PubMed ID: 31404103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
    Tappenden P; Jones R; Paisley S; Carroll C
    Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and accuracy of aortic and periaortic CT-guided percutaneous core needle biopsy.
    Pitot MA; Gu CN; Adamo DA; Kurup AN; Schmitz JJ; Packard AT
    Abdom Radiol (NY); 2023 Jun; 48(6):2148-2156. PubMed ID: 36939909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer.
    Stevenson JP; Langer CJ; Somer RA; Evans TL; Rajagopalan K; Krieger K; Jacobs-Small M; Dyanick N; Milcarek B; Coakley S; Walker S; Eaby-Sandy B; Hageboutros A
    Cancer; 2012 Nov; 118(22):5580-7. PubMed ID: 22544579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.